A prescription medicine for adults with chronic inflammatory demyelinating polyneuropathy (CIDP)

STAY UP TO DATE

Talk with someone living with CIDP who is taking VYVGART Hytrulo

Share your CIDP journey and hear from someone who has experience with VYVGART Hytrulo. Whether by phone or video call, you choose how to connect with your mentor.

ENROLL NOW

Call 1-833-HYTRULO (1-833-498-7856) to connect with a mentor!

Connect one-on-one with a VYVGART Hytrulo Mentor who shares your understanding of CIDP—because they’re also living with it every day

Your mentor is someone who can...

Explain how they’ve successfully worked with their care team to take note of their symptoms and set a treatment plan

Listen to your thoughts and personal experiences with CIDP

Provide tools to help you prepare for goal-setting conversations with your doctor

Share their experiences with the My VYVGART Path Patient Support Program and in partnering with a Nurse Case Manager

Enroll Now

Signing up only takes a few minutes

Fill out the form below or call 1-833-HYTRULO (1-833-498-7856) to enroll, and a member of our team will reach out to schedule your first mentor conversation.

Enroll in My VYVGART Hytrulo Journey

*Indicates required field.

First name*

Last name*

Tell us about yourself.*

Describe I have CIDP I care for someone with CIDP I know someone with CIDP

Are you or your loved one currently receiving VYVGART Hytrulo?

Are you or your loved one currently receiving VYVGART Hytrulo? Yes No

Contact information

Email address*

Mobile phone*

Time zone*

Receive voicemail I agree to receive voicemails if necessary at the phone number provided.*

Receive text messages I agree to receive text messages at the phone number provided. Data rates may apply.*

agreement I am 18 years of age or older.*

Privacy I agree to the statements below and have read and accept the Privacy Policy.*

View Privacy Policy

I am a U.S. resident^† and I authorize argenx US Inc. (“argenx”), its affiliates, and companies working with argenx to use my contact information and health information (“Information”) to contact me by direct mail, email, telephone, and autodialed text message for marketing purposes, such as to provide me with information, offers, and promotions regarding chronic inflammatory demyelinating polyneuropathy, argenx products and programs, to conduct market research or surveys, and to use my Information to develop future products, services, and programs.

I understand that I may withdraw my authorization provided above by emailing privacy@argenx.com or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 2 years. Copies of this authorization may be obtained by emailing privacy@argenx.com.

^†Please be aware that this mailing list is intended for U.S. residents only. The processing of your personal data is regulated by local laws and requirements, which may not offer the same level of protection as those in your country of residency.

Thank you for signing up

A representative will be in touch within the next 2 business days to schedule your first mentor conversation.

Thank you, !

A representative will be in touch within the next 2 business days to schedule your first mentor conversation.

Thank you for signing up!

You’re now signed up to receive more information and updates about VYVGART.

You’re now signed up to receive more information and updates about VYVGART. You’ll also be receiving a call from a VYVGART Educator [within a few business days].

Help at every step in understanding your VYVGART treatment

My VYVGART Path is a Patient Support Program that provides personalized support from a Nurse Case Manager and committed support team.

Learn more about VYVGART Hytrulo

Downloadable resources

This library of useful materials can help you feel informed and empowered throughout your VYVGART Hytrulo experience.

Get the resources

Self-injection with the VYVGART Hytrulo prefilled syringe

The first and only self-injection for CIDP that takes about 20-30 seconds.*

Discover more

*Please see Patient Information. Follow appropriate administration steps in the Instructions for Use. Monitor for signs and symptoms of an allergic reaction for at least 30 minutes after injection. If an allergic reaction occurs, you should seek medical attention.

Have questions? Call 1-833-VYV-CIDP (1-833-898-2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study results, cost and coverage, and more.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

have an infection or fever.
have recently received or are scheduled to receive any vaccinations.
have any history of allergic reactions.
have kidney (renal) problems.
are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
- Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
- fever
- chills
- frequent and painful urination
- cough
- pain and blockage of nasal passages
- wheezing
- shortness of breath
- sore throat
- excess phlegm
- nasal discharge
Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
- rash
- swelling of the face, lips, throat, or tongue
- shortness of breath
- hives
- trouble breathing
- low blood pressure
- fainting
Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
- high blood pressure
- chills
- shivering
- chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

IMPORTANT SAFETY INFORMATION

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

have an infection or fever.
have recently received or are scheduled to receive any vaccinations.
have any history of allergic reactions.
have kidney (renal) problems.
are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
- Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
- fever
- chills
- frequent and painful urination
- cough
- pain and blockage of nasal passages
- wheezing
- shortness of breath
- sore throat
- excess phlegm
- nasal discharge
Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
- rash
- swelling of the face, lips, throat, or tongue
- shortness of breath
- hives
- trouble breathing
- low blood pressure
- fainting
Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
- high blood pressure
- chills
- shivering
- chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

have an infection or fever.
have recently received or are scheduled to receive any vaccinations.
have any history of allergic reactions.
have kidney (renal) problems.
are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
- Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
- fever
- chills
- frequent and painful urination
- cough
- pain and blockage of nasal passages
- wheezing
- shortness of breath
- sore throat
- excess phlegm
- nasal discharge
Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
- rash
- swelling of the face, lips, throat, or tongue
- shortness of breath
- hives
- trouble breathing
- low blood pressure
- fainting
Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
- high blood pressure
- chills
- shivering
- chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

Questions? Call 1-833-VYV-CIDP
(1-833-898-2437)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

VYVGART and VYVGART Hytrulo are registered trademarks of argenx.

LIVE VYVIDLY and THAT’S LIVING VYVIDLY are trademarks of argenx.

For U.S. audiences only.

US-VYV_HYT-24-00132 V3 08/2025

Talk with someone living with CIDP who is taking VYVGART Hytrulo

Connect one-on-one with a VYVGART Hytrulo Mentor who shares your understanding of CIDP—because they’re also living with it every day

Explain how they’ve successfully worked with their care team to take note of their symptoms and set a treatment plan

Listen to your thoughts and personal experiences with CIDP

Provide tools to help you prepare for goal-setting conversations with your doctor

Share their experiences with the My VYVGART Path Patient Support Program and in partnering with a Nurse Case Manager

Signing up only takes a few minutes

Enroll in My VYVGART Hytrulo Journey

Thank you for signing up

Thank you, !

Thank you for signing up!

Learn more about VYVGART Hytrulo

Downloadable resources

Self-injection with the VYVGART Hytrulo prefilled syringe

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

VYVGART HYTRULO can cause side effects which can be serious, including:

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

IMPORTANT SAFETY INFORMATION

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

VYVGART HYTRULO can cause side effects which can be serious, including:

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

VYVGART HYTRULO can cause side effects which can be serious, including:

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?

What is VYVGART HYTRULO^® (efgartigimod alfa and hyaluronidase-qvfc)?